诺瓦瓦克斯医药 - FDA批准将Nuvaxovid授权转移至赛诺菲 - SEC文件

投资观察
Nov 20, 2025

11月4日 - 诺瓦瓦克斯医药公司公告:FDA已批准将Nuvaxovid的授权转移至赛诺菲。根据SEC文件,Nuvaxovid的市场授权转移将促使赛诺菲向诺瓦瓦克斯支付2500万美元。诺瓦瓦克斯预计将在2026年第一季度收到赛诺菲的里程碑付款。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10